MYO7A (Unconventional myosin-VIIa) variants and mutations
MYO7A (also known as Unconventional myosin-VIIa) is a human protein-coding gene encoding an unconventional myosin-VIIa protein. Its actin-based motor supports stereocilia organization in inner-ear hair cells and transport processes in retinal cells. Biallelic pathogenic variants cause Usher syndrome type 1B, while other alleles can cause nonsyndromic hearing loss. This analysis covers 3,392 MYO7A variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes Usher syndrome type 1B, autosomal recessive nonsyndromic hearing loss 2, and Usher syndrome. Example MYO7A variants include M1I, M1V, and V2L.
Variant analysis overview
- Gene: MYO7A
- Protein: Unconventional myosin-VIIa
- UniProt accession: Q13402
- Organism: Homo sapiens
- Variants analyzed: 3392
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 3,231 unspecified-consequence records; 81 missense variants; 12 frameshift variants; 57 synonymous variants; 3 in-frame insertions; 1 in-frame deletions; 3 splice-region variants; 1 stop-gained variants; 3 substitution
- Prediction scores: 2,653 variants have prediction scores (78% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Usher syndrome type 1B, autosomal recessive nonsyndromic hearing loss 2, Usher syndrome, autosomal dominant nonsyndromic hearing loss 11, deafness, Usher syndrome type 1, hearing loss, autosomal recessive, nonsyndromic genetic hearing loss, Retinal dystrophy, Rare genetic deafness, Usher syndrome type 2, Joubert syndrome and related disorders.
Protein structure and variant hotspots
- Protein features: 11 domains; 1 binding sites; 2 post-translational modification sites.
- Structural context: 2,791 variants have structural context.
- PTM context: 4 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable MYO7A variants
Examples include M1I, M1V, V2L, V2M, V2E, V2A, I3M, I3I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs782787126, ClinGen CA6196971, ClinVar RCV000668632, ClinVar RCV001203639, MetaLR 0.53, MetaSVM 0.11, Pathogenic/Likely pathogenic, not provided; Autosomal recessive nonsyndromic hearing loss 2; Autosomal dominan
- M1V (p.Met1Val), rs797044518, ClinGen CA278743, ClinVar RCV000156361, ClinVar RCV002463651, MetaLR 0.51, MetaSVM -0.08, Pathogenic/Likely pathogenic, Usher syndrome; Rare genetic deafness; not provided
- V2L (p.Val2Leu), TOPMed rs1157203537, gnomAD rs1157203537, REVEL 0.32, CADD 23.40, Uncertain significance, Inborn genetic diseases
- V2M (p.Val2Met), gnomAD 11-77130638-G-A, REVEL 0.56, CADD 24.20
- V2E (p.Val2Glu), gnomAD 11-77130639-T-A, REVEL 0.78, CADD 26.60
- V2A (p.Val2Ala), gnomAD 11-77130639-T-C, REVEL 0.42, CADD 24.00
- I3M (p.Ile3Met), gnomAD 11-77130643-T-G, REVEL 0.39, CADD 22.30
- I3I (p.Ile3Ile), gnomAD 11-77130643-T-C, CADD 11.60
- L4I (p.Leu4Ile), NCI-TCGA Cosmic COSV5369, cosmic curated COSV53691, REVEL 0.19, CADD 22.30, Variant assessed as somatic; moderate impact.
- L4D (p.Leu4Asp), rs1950740691, gnomAD 11-77130638-G-GTG, CADD 31.00
- Q5* (p.Gln5Ter), rs1950740762, ClinGen CA381946787, ClinVar RCV001204835, Ensembl rs1950740762, Pathogenic
- Q5K (p.Gln5Lys), gnomAD 11-77130647-C-A, REVEL 0.33, CADD 22.70
- Q6E (p.Gln6Glu), gnomAD 11-77130650-C-G, REVEL 0.27, CADD 19.00
- G7E (p.Gly7Glu), ExAC rs781989117, gnomAD rs781989117, Pathogenic
- G7R (p.Gly7Arg), rs372509310, ClinGen CA6197006, ClinVar RCV000988597, ClinVar RCV001036437, REVEL 0.93, CADD 33.00, Conflicting interpretations, not provided; Inborn genetic diseases
- G7V (p.Gly7Val), rs781989117, ClinGen CA6197007, ClinVar RCV000681538, ClinVar RCV001212886, REVEL 0.94, CADD 29.70, Pathogenic/Likely pathogenic, not provided; Usher syndrome; Autosomal recessive nonsyndromic hearing loss 2
- G7W (p.Gly7Trp), gnomAD 11-77142709-G-T, REVEL 0.94, CADD 33.00
- G7A (p.Gly7Ala), gnomAD 11-77142710-G-C, REVEL 0.92, CADD 28.80
- p.Gly7 Asp8insArg, gnomAD 11-77142711-G-GCG, CADD 20.20
- D8G (p.Asp8Gly), NCI-TCGA TCGA novel, TOPMed rs1951299011, REVEL 0.89, CADD 27.50, Variant assessed as somatic; moderate impact.
- D8V (p.Asp8Val), rs1555048541, gnomAD 11-77138317-A-T, CADD 4.92
- D8N (p.Asp8Asn), rs1317621689, gnomAD 11-77138334-G-A, CADD 13.90
- D8Y (p.Asp8Tyr), gnomAD 11-77142712-G-T, REVEL 0.92, CADD 26.80
- D8A (p.Asp8Ala), gnomAD 11-77142713-A-C, REVEL 0.88, CADD 26.80
- D8D (p.Asp8Asp), gnomAD 11-77142714-C-T, CADD 8.30
- H9L (p.His9Leu), gnomAD rs1555051400, REVEL 0.29, CADD 20.30
- H9M (p.His9Met), gnomAD 11-77142713-AC-A, CADD 24.80
- H9D (p.His9Asp), gnomAD 11-77142715-C-G, REVEL 0.44, CADD 21.90
- H9H (p.His9His), gnomAD 11-77142717-T-C, CADD 1.80
- H9Q (p.His9Gln), gnomAD 11-77142717-T-G, REVEL 0.29, CADD 10.60
- V10A (p.Val10Ala), rs878853237, ClinGen CA16616837, ClinVar RCV000675065, ClinVar RCV001315655, REVEL 0.96, CADD 26.50, Uncertain significance, not specified; not provided
- V10M (p.Val10Met), gnomAD rs1555051405
- V10V (p.Val10Val), rs782266200, gnomAD 11-77142720-G-A, CADD 8.15
- W11* (p.Trp11Ter), rs1307924861, ClinGen CA381947513, ClinVar RCV001264284, TOPMed rs1307924861, CADD 43.00, Likely pathogenic
- W11R (p.Trp11Arg), rs374922963, gnomAD 11-77138364-T-C, CADD 21.00
- W11G (p.Trp11Gly), rs374922963, gnomAD 11-77138364-T-G, CADD 20.80
- W11L (p.Trp11Leu), gnomAD 11-77142722-G-T, REVEL 0.93, CADD 29.70
- M12I (p.Met12Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M12L (p.Met12Leu), Ensembl rs1951300044
- M12T (p.Met12Thr), rs782409363, ClinGen CA6197009, ClinVar RCV001918944, ExAC rs782409363, AlphaMissense 0.69, MetaLR 0.38, Uncertain significance, not provided
- D13E (p.Asp13Glu), rs199989979, ClinGen CA243131, ClinVar RCV000177023, ClinVar RCV001278603, REVEL 0.37, CADD 22.20, Conflicting interpretations, not provided
- D13H (p.Asp13His), rs1555051432, ClinGen CA381947541, ClinVar RCV001069821, ClinVar RCV001828521, REVEL 0.89, CADD 29.30, Uncertain significance, not provided
- D13N (p.Asp13Asn), TOPMed rs1555051432, gnomAD rs1555051432, Uncertain significance
- D13Y (p.Asp13Tyr), gnomAD 11-77142727-G-T, REVEL 0.91, CADD 31.00
- p.Asp13 Leu16delinsVal, gnomAD 11-77142727-GACCT, CADD 21.50
- D13D (p.Asp13Asp), rs199989979, gnomAD 11-77142729-C-T, CADD 9.97
- L14P (p.Leu14Pro), gnomAD 11-77142731-T-C, REVEL 0.44, CADD 21.50
- L14R (p.Leu14Arg), gnomAD 11-77142731-T-G, REVEL 0.77, CADD 22.60
- R15I (p.Arg15Ile), rs1951301206, ClinGen CA381947571, ClinVar RCV001240192, Ensembl rs1951301206, REVEL 0.28, CADD 21.20, Uncertain significance, not provided
- R15C (p.Arg15Cys), rs1294359545, gnomAD 11-77138343-C-T, CADD 7.64
- R15H (p.Arg15His), rs1950998227, gnomAD 11-77138344-G-A, CADD 1.29
- R15L (p.Arg15Leu), rs934480457, gnomAD 11-77138377-G-T, CADD 20.30
- R15R (p.Arg15Arg), gnomAD 11-77142733-A-C, CADD 9.97
- R15K (p.Arg15Lys), gnomAD 11-77142734-G-A, REVEL 0.19, CADD 15.60
- L16* (p.Leu16Ter), rs1052030, ClinGen CA6197010, ClinVar RCV000664572, ClinVar RCV000813222, CADD 38.00, Pathogenic
- L16S (p.Leu16Ser), rs1052030, ClinGen CA132353, cosmic curated COSV68684, ClinVar RCV000036163, REVEL 0.23, CADD 18.40, Likely benign, not provided
- L16L (p.Leu16Leu), rs7120446, gnomAD 11-77138372-G-T, CADD 15.60
- G17R (p.Gly17Arg), ExAC rs782098316, gnomAD rs782098316, REVEL 0.44, CADD 22.40
- G17A (p.Gly17Ala), rs968414959, gnomAD 11-77138359-G-C, CADD 16.10
- G17V (p.Gly17Val), rs968414959, gnomAD 11-77138359-G-T, CADD 16.00
- G17G (p.Gly17Gly), gnomAD 11-77142741-G-A, CADD 7.41
- Q18* (p.Gln18Ter), rs1555051455, ClinGen CA381947603, ClinVar RCV000610416, ClinVar RCV000668877, CADD 38.00, Pathogenic
- Q18H (p.Gln18His), rs371849195, ClinGen CA6197013, ClinVar RCV000658025, ClinVar RCV001835061, REVEL 0.25, CADD 19.10, Uncertain significance, not provided
- Q18Q (p.Gln18Gln), gnomAD 11-77142744-G-A, CADD 8.66
- E19* (p.Glu19Ter), rs781869170, ClinGen CA381947615, ClinVar RCV001386770, ExAC rs781869170, CADD 39.00, Pathogenic
- E19Q (p.Glu19Gln), ExAC rs781869170, gnomAD rs781869170, REVEL 0.73, CADD 22.70, Pathogenic
- E19C (p.Glu19Cys), gnomAD 11-77138312-G-GTG, CADD 15.30
- p.Glu2 Asp3insHisProAla, rs1555048538, gnomAD 11-77138315-G-GCA, CADD 16.40
- F20S (p.Phe20Ser), rs1165311535, gnomAD 11-77138395-T-C, CADD 21.10
- F20I (p.Phe20Ile), gnomAD 11-77142748-T-A, REVEL 0.78, CADD 24.30
- F20F (p.Phe20Phe), rs1555051466, gnomAD 11-77142750-C-T, CADD 1.06
- D21N (p.Asp21Asn), rs782546306, ClinGen CA6197015, ClinVar RCV001048922, ClinVar RCV001274686, REVEL 0.38, CADD 22.70, Uncertain significance, Inborn genetic diseases
- D21Y (p.Asp21Tyr), gnomAD 11-77142751-G-T, REVEL 0.77, CADD 26.30
- D21D (p.Asp21Asp), rs782795012, gnomAD 11-77142753-C-T, CADD 2.02
- V22A (p.Val22Ala), rs1555051493, ClinGen CA381947688, ClinVar RCV003699681, AlphaMissense 0.82, MetaLR 0.77, Uncertain significance, not provided
- V22G (p.Val22Gly), gnomAD rs1555051493, REVEL 0.92, AlphaMissense 0.82
- V22L (p.Val22Leu), rs376701580, ClinGen CA6197018, cosmic curated COSV10128, ClinVar RCV001565152, REVEL 0.69, CADD 26.00, Uncertain significance, Inborn genetic diseases; not specified; not provided
- V22M (p.Val22Met), rs376701580, ClinGen CA6197017, ClinVar RCV001774368, ClinVar RCV002539163, REVEL 0.70, CADD 26.70, Uncertain significance, Inborn genetic diseases; not provided
- V22E (p.Val22Glu), gnomAD 11-77142755-T-A, REVEL 0.92, CADD 26.90
- P23P (p.Pro23Pro), rs372668137, gnomAD 11-77138321-C-T, CADD 4.10
- P23T (p.Pro23Thr), rs2135564428, gnomAD 11-77138328-C-A, CADD 3.29
- P23R (p.Pro23Arg), rs991138064, gnomAD 11-77138338-C-G, CADD 6.89
- P23L (p.Pro23Leu), rs1417013483, gnomAD 11-77138356-C-T, CADD 8.03
- P23Q (p.Pro23Gln), rs1050504274, gnomAD 11-77138416-C-A, CADD 17.40
- I24F (p.Ile24Phe), ExAC rs200872817, TOPMed rs200872817, gnomAD rs200872817, REVEL 0.49, CADD 23.40
- I24V (p.Ile24Val), ExAC rs200872817, TOPMed rs200872817, gnomAD rs200872817, REVEL 0.25, CADD 18.90
- I24I (p.Ile24Ile), rs397516334, gnomAD 11-77142762-C-T, CADD 9.23
- G25R (p.Gly25Arg), rs782252317, ClinGen CA278727, cosmic curated COSV10534, ClinVar RCV000154329, REVEL 0.94, CADD 27.90, Pathogenic, not provided; Retinal dystrophy; Usher syndrome type 1B
- G25W (p.Gly25Trp), ExAC rs782252317, TOPMed rs782252317, gnomAD rs782252317, REVEL 0.92, CADD 29.00, Pathogenic, in USH1B
- G25V (p.Gly25Val), gnomAD 11-77142764-G-T, REVEL 0.93, CADD 26.30
- G25A (p.Gly25Ala), gnomAD 11-77142764-G-C, REVEL 0.78, CADD 25.70
- G25G (p.Gly25Gly), rs782517795, gnomAD 11-77142765-G-C, CADD 6.51
- A26E (p.Ala26Glu), rs369125667, ClinGen CA278728, ClinVar RCV000154340, ClinVar RCV002516104, REVEL 0.85, CADD 25.20, Pathogenic/Likely pathogenic, not provided; Usher syndrome type 1B; Rare genetic deafness
- A26T (p.Ala26Thr), Ensembl rs2135627538, REVEL 0.78, CADD 26.80
- A26V (p.Ala26Val), rs369125667, ClinGen CA6197021, ClinVar RCV002632979, ESP rs369125667, REVEL 0.80, CADD 25.80, Uncertain significance, not provided
- p.Ala5 Asp6insAsnProAla, rs1555048553, gnomAD 11-77138321-C-CGC, CADD 6.58
- A26A (p.Ala26Ala), rs1188922296, gnomAD 11-77138324-C-T, CADD 3.62
- V27E (p.Val27Glu), rs1951305171, ClinGen CA381926323, ClinVar RCV001883030, TOPMed rs1951305171, REVEL 0.53, CADD 22.90, Uncertain significance, not provided
- V27V (p.Val27Val), rs1555051535, gnomAD 11-77142771-G-A, CADD 10.50
- V28G (p.Val28Gly), Ensembl rs1591200836
- V28V (p.Val28Val), rs782307156, gnomAD 11-77142774-G-A, CADD 9.46
- K29E (p.Lys29Glu), NCI-TCGA Cosmic COSV1012, cosmic curated COSV10128, Variant assessed as somatic; moderate impact.
- K29M (p.Lys29Met), Ensembl rs1951305820, REVEL 0.84, CADD 27.80
- K29K (p.Lys29Lys), rs1951305977, gnomAD 11-77142777-G-A, CADD 9.31
- L30L (p.Leu30Leu), rs1951003260, gnomAD 11-77138414-G-C, CADD 17.50
- L30V (p.Leu30Val), gnomAD 11-77142778-C-G, REVEL 0.38, CADD 18.50
- L30P (p.Leu30Pro), gnomAD 11-77142778-CT-C, CADD 27.60
- C31* (p.Cys31Ter), rs35689081, ClinGen CA277965, ClinVar RCV000012634, ClinVar RCV000154341, CADD 27.00, Pathogenic
- C31C (p.Cys31Cys), rs35689081, gnomAD 11-77142783-C-T, CADD 3.37
- C31W (p.Cys31Trp), gnomAD 11-77142783-C-G, REVEL 0.64, CADD 16.80
- D32H (p.Asp32His), ExAC rs782363121, TOPMed rs782363121, gnomAD rs782363121, REVEL 0.67, CADD 24.60, Uncertain significance
- D32N (p.Asp32Asn), rs782363121, ClinGen CA6197024, ClinVar RCV003215611, ExAC rs782363121, REVEL 0.54, CADD 26.90, Uncertain significance, Inborn genetic diseases
- D32Y (p.Asp32Tyr), gnomAD 11-77142784-G-T, REVEL 0.81, CADD 27.20
- D32D (p.Asp32Asp), rs369794074, gnomAD 11-77142786-C-T, CADD 9.29
- S33F (p.Ser33Phe), Ensembl rs1565310188, REVEL 0.83, CADD 26.20
- S33P (p.Ser33Pro), ESP rs373662540
- S33T (p.Ser33Thr), gnomAD 11-77142787-T-A, REVEL 0.29, CADD 23.40
- S33C (p.Ser33Cys), gnomAD 11-77142788-C-G, REVEL 0.73, CADD 25.60
- G34P (p.Gly34Pro), rs1476080508, gnomAD 11-77138404-A-ACG, CADD 3.45
- G34A (p.Gly34Ala), rs782312060, gnomAD 11-77142788-CTG-C, CADD 31.00
- G34W (p.Gly34Trp), gnomAD 11-77142790-G-T, REVEL 0.88, CADD 29.90
- G34G (p.Gly34Gly), rs782400814, gnomAD 11-77142792-G-A, CADD 9.82
- Q35* (p.Gln35Ter), rs1951307710, ClinGen CA381926455, ClinVar RCV001264286, Ensembl rs1951307710, Likely pathogenic
- Q35H (p.Gln35His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q35R (p.Gln35Arg), rs2135627311, ClinGen CA2573147683, ClinVar RCV001960750, Ensembl rs2135627311, Pathogenic
- Q35K (p.Gln35Lys), gnomAD 11-77142793-C-A, REVEL 0.50, CADD 18.50
- V36I (p.Val36Ile), TOPMed rs1201506175, gnomAD rs1201506175, REVEL 0.22, CADD 12.20, Uncertain significance, not provided
- V36V (p.Val36Val), gnomAD 11-77142798-C-T, CADD 10.30
- Q37* (p.Gln37Ter), rs1951308166, ClinGen CA381926505, cosmic curated COSV68683, ClinVar RCV001263712, Pathogenic
- Q37H (p.Gln37His), rs1461064082, ClinGen CA381926518, ClinVar RCV002018664, TOPMed rs1461064082, AlphaMissense 0.35, MetaLR 0.48, Uncertain significance, not provided
- Q37Q (p.Gln37Gln), rs1461064082, gnomAD 11-77142801-G-A, AlphaMissense 0.35, MetaLR 0.48
- V38G (p.Val38Gly), Ensembl rs1591201098
- V38V (p.Val38Val), gnomAD 11-77142804-G-A, CADD 11.70
- V39L (p.Val39Leu), Ensembl rs900210990
- V39A (p.Val39Ala), gnomAD 11-77142806-T-C, REVEL 0.14, CADD 20.80
- V39V (p.Val39Val), rs1555051569, gnomAD 11-77142807-G-A, CADD 11.40
- D40G (p.Asp40Gly), rs2135628856, ClinGen CA381926566, ClinVar RCV001767885, Ensembl rs2135628856, AlphaMissense 0.94, MetaLR 0.50, Uncertain significance, not provided
- D40N (p.Asp40Asn), gnomAD 11-77142808-G-A, REVEL 0.48, CADD 31.00
- D41E (p.Asp41Glu), Ensembl rs931895407
- D41N (p.Asp41Asn), ExAC rs782032952, gnomAD rs782032952, REVEL 0.52, CADD 32.00, Uncertain significance
- D41Y (p.Asp41Tyr), rs782032952, ClinGen CA381926581, ClinVar RCV002650452, ExAC rs782032952, REVEL 0.79, CADD 31.00, Uncertain significance, not provided
- E42K (p.Glu42Lys), NCI-TCGA Cosmic COSV6868, cosmic curated COSV68686, Variant assessed as somatic; moderate impact.
- E42V (p.Glu42Val), gnomAD 11-77142815-A-T, REVEL 0.68, CADD 32.00
- E42E (p.Glu42Glu), rs782039375, gnomAD 11-77142816-A-G, CADD 12.70
- D43Y (p.Asp43Tyr), gnomAD 11-77142817-G-T, REVEL 0.25, CADD 24.90
- D43D (p.Asp43Asp), rs2135629106, gnomAD 11-77142819-C-T, CADD 11.60
- N44S (p.Asn44Ser), Ensembl rs1951309867, REVEL 0.10, CADD 24.70
- N44N (p.Asn44Asn), rs782722303, gnomAD 11-77142822-T-C, CADD 9.14
- E45* (p.Glu45Ter), rs368877140, ClinGen CA6197057, ClinVar RCV000597639, ESP rs368877140, CADD 56.00, Pathogenic
- E45A (p.Glu45Ala), TOPMed rs1383661917, gnomAD rs1383661917, REVEL 0.56, CADD 32.00
- E45G (p.Glu45Gly), TOPMed rs1383661917, gnomAD rs1383661917, REVEL 0.65, CADD 32.00, Uncertain significance, Inborn genetic diseases; not provided
- E45K (p.Glu45Lys), NCI-TCGA Cosmic COSV1012, cosmic curated COSV10128, Variant assessed as somatic; moderate impact.
- E45V (p.Glu45Val), gnomAD 11-77147799-A-T, REVEL 0.62, CADD 32.00
- E45E (p.Glu45Glu), gnomAD 11-77147800-A-G, CADD 3.93
- H46Q (p.His46Gln), gnomAD rs1555054593, REVEL 0.16, CADD 21.90
- H46Y (p.His46Tyr), gnomAD 11-77147801-C-T, REVEL 0.38, CADD 24.30
- W47* (p.Trp47Ter), rs397516285, ClinGen CA278627, cosmic curated COSV10657, ClinVar RCV000036050, CADD 33.00, Pathogenic
- W47C (p.Trp47Cys), Ensembl rs397516285, Pathogenic
- W47R (p.Trp47Arg), gnomAD 11-77147804-T-C, REVEL 0.48, CADD 23.60
- I48V (p.Ile48Val), Ensembl rs1951683564, REVEL 0.23, CADD 22.70
- I48I (p.Ile48Ile), gnomAD 11-77147809-C-T, CADD 9.96
- S49S (p.Ser49Ser), gnomAD 11-77147812-T-A, CADD 9.93
- P50L (p.Pro50Leu), rs372170717, ClinGen CA6197059, ClinVar RCV001885771, ESP rs372170717, REVEL 0.30, AlphaMissense 0.15, Uncertain significance, not provided
- P50Q (p.Pro50Gln), rs372170717, ClinGen CA6197058, ClinVar RCV002781283, ClinVar RCV005439084, AlphaMissense 0.15, MetaLR 0.30, Uncertain significance, not provided; Inborn genetic diseases
- P50S (p.Pro50Ser), gnomAD 11-77147813-C-T, REVEL 0.26, CADD 23.50
- P50P (p.Pro50Pro), rs782777804, gnomAD 11-77147815-G-T, CADD 7.39
- Q51P (p.Gln51Pro), rs375662903, ClinGen CA6197061, ClinVar RCV001375135, ESP rs375662903, REVEL 0.47, CADD 27.00, Uncertain significance, Hearing impairment
- N52K (p.Asn52Lys), rs886048669, ClinGen CA381928672, ClinVar RCV002735186, ClinGen CA10639457, REVEL 0.11, CADD 4.67, Uncertain significance, not provided
- N52S (p.Asn52Ser), gnomAD rs1591224316, REVEL 0.11, CADD 15.80
- N52T (p.Asn52Thr), gnomAD rs1591224316
- N52N (p.Asn52Asn), rs886048669, gnomAD 11-77147821-C-T, CADD 2.62
- A53S (p.Ala53Ser), Ensembl rs1565320027
- A53T (p.Ala53Thr), gnomAD 11-77147822-G-A, REVEL 0.36, CADD 24.10
- A53A (p.Ala53Ala), gnomAD 11-77147824-A-C, CADD 13.50
- T54A (p.Thr54Ala), rs369142107, ClinGen CA6197062, ClinVar RCV000298034, ClinVar RCV000355269, REVEL 0.08, CADD 19.60, Conflicting interpretations, Usher syndrome type 1; Autosomal dominant nonsyndromic hearing loss 11; not prov
- T54M (p.Thr54Met), ExAC rs782568869, TOPMed rs782568869, gnomAD rs782568869, REVEL 0.20, CADD 22.20, Uncertain significance
- T54R (p.Thr54Arg), rs782568869, ClinGen CA381928699, ClinVar RCV001899321, ExAC rs782568869, REVEL 0.14, CADD 17.10, Uncertain significance, not provided
- T54K (p.Thr54Lys), gnomAD 11-77147826-C-A, REVEL 0.12, CADD 17.40
- T54T (p.Thr54Thr), rs782185833, gnomAD 11-77147827-G-C, CADD 8.48
- H55D (p.His55Asp), TOPMed rs1951685286
Public MYO7A analysis runs
- MYO7A analysis run — MYO7A (3,392 variants) — completed 2026-08-18